🇺🇸 FDA
Patent

US 8440208

Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease

granted A61KA61K39/118A61P

Quick answer

US patent 8440208 (Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease) held by The Board of Regents of the University of Texas System expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K39/118, A61P, A61P31/04, A61P37/04